IFN gamma/IFNG, Human
| $90.00 | |
| Z05401-100 | |
|
|
|
|
|
|
|
|
|
| Ask us a question | |
IVD Raw Materials
| $90.00 | |
| Z05401-100 | |
|
|
|
|
|
|
|
|
|
| Ask us a question | |
| Species | Human | |
| Protein Construction |
|
|
| Purity | > 95% as determined by BisTris PAGE | |
| Endotoxin Level | Less than 0.01EU per μg by the LAL method. | |
| Biological Activity | Measured by its binding ability in a functional ELISA. Test result was comparable to standard batch. | |
| Expression System | E.coli | |
| Theoretical Molecular Weight | 16.77 kDa | |
| Apparent Molecular Weight | The protein has a predicted MW of 16.77 kDa same as Bis-Tris PAGE result. | |
| Formulation | Lyophilized from 0.22μm filtered solution in 50mM Tris (pH 8.0). | |
| Reconstitution | Centrifuge the tube before opening. Reconstituting to a concentration more than 100 μg/ml is recommended. Dissolve the lyophilized protein in distilled water. | |
| Storage & Stability | Upon receiving, the product remains stable for 6 months at -20℃ or below. Upon reconstitution, the product should be stable for 3 months at -80℃. Avoid repeated freeze-thaw cycles. |
Immobilized IFN gamma/IFNG, Human, No Tag at 5 μg /ml (100 μl/well) on the plate. Dose response curve for Human IFNGR1, hFc Tag with the EC50 of 17.6ng/ml determined by ELISA. »
The purity of IFN gamma/IFNG, Human is greater than 95% as determined by SEC-HPLC. »
IFN gamma/IFNG, Human on Bis-Tris PAGE under reduced condition. The purity is greater than 95%. »
| Target Background | Interferon-gamma (IFN gamma) is a cytokine that plays physiologically important roles in promoting innate and adaptive immune responses. The absence of IFN gamma production or cellular responsiveness in humans and experimental animals significantly predisposes the host to microbial infection, a result that validates the physiologic importance of this cytokine in preventing infectious disease. |
| Synonyms | Interferon-gamma; Interferon-γ; interferon; gamma; IFG; IFI; IFN gamma; IFNγ; IFN γ |
For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use.